Abnormal AI
AI security · https://abnormal.ai
Verdict: Buy · Confidence: medium · Reviewed 2026-10-15
Abnormal AI sells AI detection for email and cloud account attacks. On August 6, 2024 it announced a $250 million Series D at a $5.1 billion valuation, $546 million in total expected proceeds, more than $200 million in ARR, and 100%+ year-over-year ARR growth. More than 2,400 organizations, including 17% of the Fortune 500, were customers. No later public revenue update was found, and no gross margin was disclosed.
Rubric
| Dimension | Score (1–5) | Notes & sources |
|---|---|---|
| Real customers & revenue quality Are there named paying customers, recurring revenue, and retention evidence? | 5/5 | Abnormal said it had recently crossed $200 million in ARR with 100%+ year-over-year increases, and that more than 2,400 organizations trust it, including 17% of the Fortune 500. O-I Glass's CIO is quoted as a customer. The figure is from August 2024; no newer ARR was found.
|
| Unit economics Do gross margins survive inference/compute costs? Is pricing durable? | Unknown | Unknown — no public figure found. |
| Moat Proprietary data, distribution, switching costs, or tech that is hard to copy? | 4/5 | The product baselines human behavior across email and SaaS APIs, which improves with tenant data, and it covers Microsoft 365, Google Workspace, and apps including Workday, Salesforce, ServiceNow, Slack, and AWS. That behavioral history is harder to copy than a signature filter.
|
| Platform risk Could a model provider or incumbent ship this as a feature? (higher score = lower risk) | 3/5 | Deployment is an API into Microsoft 365 and Google Workspace, so the company depends on those platforms' APIs and on their own security add-ons. Abnormal is not a feature inside one suite, but Microsoft or Google can bundle overlapping detection.
|
| Team & execution Shipping cadence, leadership track record, stability. | 4/5 | CEO Evan Reiser closed a Wellington-led $250 million round with Greylock, Menlo, Insight, and CrowdStrike Falcon Fund, after crossing $200 million ARR. The company said it was preparing for the public market. No IPO filing was found in the pages opened.
|
| Funding vs. traction Is capital raised justified by verifiable traction? | 4/5 | $546 million of expected proceeds and a $5.1 billion valuation sit against more than $200 million ARR growing over 100%. The valuation is rich, and it is attached to disclosed subscription scale rather than a pre-revenue story.
|
| Hype signals Demo-driven marketing, vague metrics, valuation outrunning evidence? (higher score = fewer red flags) | 4/5 | The release pairs the valuation with ARR, growth, and a customer count. The staleness of the August 2024 figure is a gap, not a contradiction of the traction that was disclosed.
|
Listing source: https://abnormal.ai. Revenue, users, and valuation figures appear only when publicly sourced; otherwise they are marked unknown.